Soligenix, Inc. (SNGX) Stock Forecast

NASDAQ: SNGXAnalyst ratings, price target and estimates.

SNGX analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
5.00 / 5 from 1 analysts
Price target
$1.38
average of analyst targets
Upside to target
+292.9%
from the latest close
Next earnings
November 6, 2026
EPS estimate $-0.12
52-week range
$0.28 – $1.70

SNGX analyst ratings

1 analysts
Strong buy
1100%
Buy
00%
Hold
00%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

SNGX price target

Price $0.35Target $1.38
52-week low $0.2852-week high $1.70

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

SNGX earnings per share estimates

Soligenix, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.09−$0.09−$0.09−$0.58+84.5%1
Current fiscal year (2026)−$0.40−$0.40−$0.40−$2.14+81.3%1
Next fiscal year (2027)−$0.25−$0.25−$0.25−$0.40+37.5%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

SNGX revenue estimates

Soligenix, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$0$0$00.0%1
Current fiscal year (2026)$0$0$00.0%2
Next fiscal year (2027)$0$0$00.0%2

SNGX EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

SNGX EPS estimate revisions

Soligenix, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.09−$0.09−$0.09−$0.09−$0.090.0%1 up · 0 down
Current fiscal year (2026)−$0.40−$0.40−$0.40−$0.40−$0.400.0%1 up · 0 down
Next fiscal year (2027)−$0.25−$0.25−$0.25−$0.25−$0.250.0%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

SNGX earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; SNGX beat in 10 of 12.

What analysts expect from SNGX

1 analysts cover Soligenix; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $1.38, 292.9% above the latest close of $0.35. Analysts expect earnings of −$0.40 per share for 2026, +81.3% from a year earlier. For 2027 the average estimate is −$0.25 per share. Soligenix beat the EPS estimate in 10 of the last 12 quarters.

Related: SNGX income statement, SNGX key metrics, SNGX chart. See the SNGX stock overview for the latest quote and news.

SNGX forecast FAQ

What is Soligenix's price target?

The average analyst price target for Soligenix is $1.38, 292.9% above the latest close of $0.35.

Is Soligenix a buy, hold or sell?

Of 1 analysts covering Soligenix, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Soligenix's EPS forecast?

Analysts forecast −$0.40 per share for 2026 (range −$0.40 to −$0.40); for 2027 the estimate is −$0.25.

When does Soligenix report earnings?

Soligenix is expected to report results for the quarter ending September 30, 2026 on November 6, 2026; the EPS estimate is $-0.12.

Does Soligenix usually beat earnings estimates?

Soligenix reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Biotechnology: forecast